Nature's Sunshine Products (NATR) Canaccord Genuity's 46th Annual Growth Conference summary

Company background and leadership

• Founded in 1972, the company pioneered encapsulated herbal supplements and aims to elevate lives through natural health and economic opportunities.

• Operates globally with tens of thousands of independent consultants and two main brands, Nature's Sunshine and Synergy, sold in over 40 countries.

• Leadership team blends industry veterans and new talent, recently adding a new CFO with global consumer product experience.

• CEO has extensive experience in consumer packaged goods and was tasked to accelerate growth.

Financial performance and market position

• Achieved $480 million in sales and a 10% EBITDA margin in 2025, with a strong balance sheet and no debt.

• Outperformed direct selling peers with 4% annual top-line growth and 16% EBITDA growth over four years.

• Delivered total shareholder return more than twice the Russell 2000 index since 2023.

Strategic growth drivers and expansion plans

• Aims to double sales to $1 billion and improve EBITDA margin to 15% through scale and leverage.

• Four strategic drivers: geographic penetration, digital channel expansion, superior marketing, and M&A.

• Plans to expand in existing markets (e.g., Japan, Korea, China), enter new markets (recently Germany, upcoming Asian country), and grow Synergy in the U.S.

• Digital business is on track for $50 million in sales, with a focus on direct-to-consumer and retail channel expansion.